In addition, Noguchi et al. (2015) found in vitro that valproic acid can partially inhibit TGF-β-induced epithelial-to-mesenchymal transition by improving histone H3K27 acetylation reduction, thus directly alleviating pulmonary fibrosis. Here, TGFB1 is linked to pulmonary fibrosis.